Bvf Inc Monte Rosa Therapeutics, Inc. Transaction History
Bvf Inc
- $1.85 Billion
- Q3 2025
A detailed history of Bvf Inc transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 5,660,132 shares of GLUE stock, worth $81.3 Million. This represents 2.27% of its overall portfolio holdings.
Number of Shares
5,660,132
Previous 5,660,132
-0.0%
Holding current value
$81.3 Million
Previous $25.5 Million
64.3%
% of portfolio
2.27%
Previous 1.0%
Shares
2 transactions
Others Institutions Holding GLUE
# of Institutions
124Shares Held
54.9MCall Options Held
193KPut Options Held
241K-
Nea Management Company, LLC Timonium, MD7.69MShares$110 Million3.56% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$81.2 Million68.34% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$70.6 Million0.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.64MShares$66.6 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.36MShares$48.2 Million0.75% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $671M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...